Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRUST-2: TSO in Active Crohn's Disease
NCT01279577Phase 2Completed
- Sponsor
- Dr. Falk Pharma GmbH
- Start
- Nov 2010
- Primary completion
- Feb 2014
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of trichuris suis ova in Crohn's disease, sponsored by Dr. Falk Pharma GmbH. Started Nov 2010; status: completed.
02
Drugs
trichuris suis ova
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT01279577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01279577.